Why Does Obesity Increase the Risk for Cardiovascular Disease?

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|19|32|5678-5683

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.32, 2013-10, pp. : 5678-5683

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Does Non-Alcoholic Fatty Liver Disease (NAFLD) Increase Cardiovascular Risk?

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 8, Iss. 4, 2008-12 ,pp. : 301-307

Bentham Science Publishers

Access to resources Recommend Favorite

-adrenoceptor agonists increase cardiovascular risk

By  

Inpharma, Vol. 1, Iss. 1451, 2004-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Inflammation, Adiponectin, Obesity and Cardiovascular Risk

By  

Current Medicinal Chemistry, Vol. 17, Iss. 36, 2010-12 ,pp. : 4511-4520

Bentham Science Publishers

Access to resources Recommend Favorite

Drug Treatment of Obesity in Cardiovascular Disease

By Charakida Marietta   Finer Nicholas  

American Journal of Cardiovascular Drugs, Vol. 12, Iss. 2, 2012-04 ,pp. : 93-104

Adis International

Access to resources Recommend Favorite

Triptans: no increase in stroke or cardiovascular event risk

By  

Inpharma, Vol. 1, Iss. 1429, 2004-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite